background image

Paid Clinical Trials Missoula

Discover 132 paid clinical trials in Missoula, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

for
Asthma
Location: 17 recruiting locations
Sponsor: GlaxoSmithKline

Sex: All

Age: 12 - 17

Code: NCT05757102

Phase3, Recruiting
Active & Responsive

A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)

for
Postmenopausal Osteoporosis
Location: 8 recruiting locations
Sponsor: Angitia Biopharmaceuticals

Sex: Female

Age: 55 - 70+

Code: NCT06577935

Phase2, Recruiting
Active & Responsive

Impella RP Flex with Smart Assist

for
Right Ventricular (RV) Dysfunction
Location: 26 recruiting locations
Sponsor: Abiomed Inc.

Sex: All

Age: 0+

Code: NCT06637644

Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza

for
Influenza
Location: 109 recruiting locations
Sponsor: Cidara Therapeutics Inc.

Sex: All

Age: 12+

Code: NCT07159763

Phase3, Recruiting
Active & Responsive

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: 89 recruiting locations
Sponsor: Cleerly, Inc.

Sex: All

Age: 55+

Code: NCT06112418

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

for
Cough, Refractory Chronic Cough
Location: 47 recruiting locations
Sponsor: Bellus Health Inc. - a GSK company

Sex: All

Age: 18 - 70+

Code: NCT05600777

Phase3, Recruiting
Active & Responsive

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

for
Recurrent Endometrial Carcinoma,
Location: 219 recruiting locations
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05554328

Phase2, Recruiting
Active & Responsive

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: 194 recruiting locations
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase3, Recruiting
Active & Responsive

Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)

for
Plantar Fibromatosis, Ledderhose Disease
Location: 53 recruiting locations
Sponsor: Endo Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06151197

Phase3, Recruiting
Active & Responsive

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

for
Obesity, Overweight
Location: 29 recruiting locations
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06972459

Phase3, Recruiting